Award
National Institute of General Medical Sciences 5P30GM159561-02
COBRE Phase III
Recipient
UNIV OF ARKANSAS FOR MED SCIS
Award Amount
$1,147,500.00
Ceiling
$1,147,500.00
Awarded
June 18, 2026
Identifier
5P30GM159561-02
Award for COBRE Phase III to establish a research center on adverse effects of cancer therapy, funded by NIGMS/NIH.
Description
The project is funded by the National Institute of General Medical Sciences (NIGMS), part of NIH. The project aims to build a self-sustaining research center focused on adverse effects of cancer therapy. The project involves multiple cores and collaboration with other NIH-supported programs. The project includes a comprehensive evaluation plan and aims to improve cancer treatment safety and survivorship.